Enovis ENOV
NYSE ENOV
$26.17 -0.32 (-1.21%)
At close: Aug 20, 2026 · 4:00 PM EDT

Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025)

Enovis (ENOV) posted quarterly Liabilities from Discontinued Operations of 1425000.0 for Q4 2025, down 99.75% quarter-over-quarter from 573562000.0 in Q4 2021.

Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025) Analysis & Trends

Enovis (ENOV) has reported Liabilities from Discontinued Operations for 6 consecutive years, with 1425000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 1425000.0; the TTM figure through Oct 2025 stood at 1425000.0 (changed N/A YoY), while the FY2021 annual figure was 573562000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations retreated to 1425000.0 in Q4 2025 per ENOV's latest filing, from 573562000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 573562000.0 in Q4 2021 and bottomed at 1425000.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Enovis 1.50 Bn 1.48 Bn 359.25 Mn

Historic Data

Download Data
DateValue
Oct 3, 2025 1.43 Mn
Oct 3, 2025 1.43 Mn
Dec 31, 2021 573.56 Mn
Dec 31, 2021 573.56 Mn
Sep 27, 2019 651.72 Mn
Sep 27, 2019 651.72 Mn
Dec 31, 2018 95.40 Mn
Dec 31, 2018 95.40 Mn
Sep 29, 2017 272.41 Mn
Sep 29, 2017 272.41 Mn
Dec 31, 2016 165.97 Mn
Dec 31, 2016 165.97 Mn